TNXP (MC $11 M) (Cash $18 M) 2x Big Phase3 readouts imminent

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
TNXP (MC $11 M) (Cash $18 M) 2x Big Phase3 readouts imminent

An SI Board Since January 2020

Posts	SubjectMarks	Bans	Symbol
1	1	0	TNXP

Emcee: BioHero	Type: Moderated

Introduction Market Data Compact

Market Cap $11 M --Cash $18 M --Shares Out only 8.5M --2 BIG Phase 3 Readouts targeting posttraumatic stress disorder (PTSD) & Fibromyalgia which are very large markets expected in 1H 2020 .Phase 3 interim results of the PTSD trial expected during this Quarter . TNXP another BRUTALLY underpriced stock which could hit $10+ in the coming weeks .SUPER STRONG BUY at this ridiculous low price .GL

Tonix Pharma (TNXP)

Market Cap: $11 M
Cash: $18 M
Price:$1.28 M

Shares Out: 8.5 M

Presentation December
content.equisolve.net

Insider buying

openinsider.com

Go to reply# or date (mm/dd/yy):